Biolex, Inc.

16 articles about Biolex, Inc.

• OctoPlus' Licensee Biolex, Inc. Makes Third Presentation At EASL Confirming Locteron's Superior Product Profile

  4/19/2010

• Biolex, Inc. Pulls Planned IPO Due to Market Conditions

  2/4/2008

• Biolex, Inc. Announces Initiation Of Locteron(TM) Phase 2 Clinical Study In Chronic Hepatitis C

  1/30/2007

• Biolex, Inc. Announces Publication In Nature Biotechnology Demonstrating Potential To Produce Monoclonal Antibodies With Increased Potency And Efficacy

  11/28/2006

• Biolex, Inc. Featured At The 9th Annual Facilities For Mammalian Cell Product Conference

  10/18/2006

• Biolex Therapeutics Announces Positive Phase 1 Results For Hepatitis C Product Candidate Locteron(TM)

  4/27/2006

• Biolex Therapeutics Announces Expansion Of Medarex, Inc. Collaboration

  4/11/2006

• Biolex Therapeutics Receives Prestigious Award For Manufacturing Facility

  3/22/2006

• Biolex Therapeutics Presents Results Highlighting Benefits Of Locteron(TM) At 'Breakthroughs In Hepatitis' Session

  2/15/2006

• Biolex Therapeutics Announces Recruitment Of Three Key Management Team Additions To Accelerate Commercialization Of Lead Programs

  11/16/2005

• Biolex Therapeutics Announces Initiation Of Phase 1 Clinical Study Of Hepatitis C Candidate Locteron(TM)

  11/2/2005

• Biolex Therapeutics And Kringle Pharma, Inc. Announce Collaboration For Production Of A Novel Protein Targeting Cancer

  10/27/2005

• Biolex Therapeutics Successfully Completes Phase 1 Study For First LEX System (TM) Produced Therapeutic Protein

  10/26/2005

• Biolex Therapeutics Doubles Manufacturing Capacity, Realizing Significant Economic And Time Efficiencies

  9/13/2005

• Biolex Therapeutics Raises $36 Million in Venture Financing

  9/1/2005

• BioPartnering Europe 2004 Exhibitor Profiles

  10/11/2004